Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears sharply divided testimony on bill to allow supervised ibogaine treatment
Summary
House Bill 4110 would allow attending physicians to provide ibogaine at certified treatment centers beginning Jan. 1, 2027; veterans and advocacy groups testified in support citing recovery stories, while forensic psychiatrists and the Oregon Medical Association urged caution citing limited evidence and cardiac risks.
The House Committee on Behavioral Health on Feb. 10 heard competing testimony over House Bill 4110, which would permit attending physicians to provide ibogaine to qualifying patients and would require consumption at certified treatment centers overseen by the Oregon Health Authority.
Sponsor Rep. Alex Carlotis said the bill is modeled on Oregon’s psilocybin framework and aims to provide supervised, domestically available care for people now traveling abroad for the treatment, including veterans with PTSD. Carlotis told the committee proponents want to avoid a large fiscal cost and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
